scholarly journals Lorlatinib Salvages CNS Relapse in an ALK-Positive Non–Small-Cell Lung Cancer Patient Previously Treated With Crizotinib and High-Dose Brigatinib

2019 ◽  
Vol 20 (2) ◽  
pp. e133-e136 ◽  
Author(s):  
Mandy R. Sakamoto ◽  
Justin M. Honce ◽  
Deborah L. Lindquist ◽  
D. Ross Camidge
Keyword(s):  
Lung Cancer ◽  
Cancer Patient ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Lung Cancer Patient ◽  
Small Cell ◽  
High Dose ◽  
Small Cell Lung ◽  
Previously Treated ◽  
Alk Positive

scholarly journals A Case Report of an EML4-ALK-positive Elderly Non-small Cell Lung Cancer Patient with a Poor PS Successfully Treated with Crizotinib

Haigan ◽  
2013 ◽  
Vol 53 (6) ◽  
pp. 782-786 ◽  
Author(s):  
Makoto Nagamata ◽  
Yusuke Okuma ◽  
Yukio Hosomi ◽  
Tsunekazu Hishima ◽  
Tatsuru Okamura
Keyword(s):  
Lung Cancer ◽  
Case Report ◽  
Cancer Patient ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Lung Cancer Patient ◽  
Small Cell ◽  
Small Cell Lung ◽  
Alk Positive

scholarly journals Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition

Oncotarget ◽  
2021 ◽  
Vol 12 (19) ◽  
pp. 1946-1952
Author(s):  
Marcel Kemper ◽  
Georg Evers ◽  
Arik Bernard Schulze ◽  
Jan Sperveslage ◽  
Christoph Schülke ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Patient ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Lung Cancer Patient ◽  
Small Cell ◽  
Resistance Mutations ◽  
Small Cell Lung ◽  
Alk Positive

scholarly journals P2.01-038 Determinants of Frailty and Treatment Toxicity in Non-Small Cell Lung Cancer Patient

2017 ◽  
Vol 12 (11) ◽  
pp. S2083-S2084
Author(s):  
M. Boucher ◽  
L. Mezquita ◽  
E. Auclin ◽  
M. Mons ◽  
J. Marghadi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Patient ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Lung Cancer Patient ◽  
Small Cell ◽  
Small Cell Lung ◽  
Treatment Toxicity
Sign in / Sign up

Export Citation Format

Share Document